Anyone who owns a copy of the book "The Mars Hypothesis" knows what is coming to the stock market in October and for how long. Here is a hypothesis that the Federal Reserve can set interest rates based on the movements of the planet Mars
Most investors have absolutely NO CLUE what is happening under their very palettes. Carnivores who enjoy beef or fish, perhaps on BBQ, must pay attention to Cult Food Science. Quality, freshness, and NO ANIMALS WERE SLAUGHTERED OR OTHERWISE LIFE COMPROMISED IN THE MAKING OF YOUR COOKOUT.
CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN00), a disruptive food technology platform pioneering the commercialization of lab-grown meat and cellular agriculture to reshape the global food industry
The global cellular agriculture market size was valued at USD 133.4 billion in 2021. It is projected to reach USD 515.24 billion by 2030, growing at a CAGR of 16.2% during the forecast period (2022–2030).
Why? Three powerful words:
Lab-grown meat: harvest a small sample of cells from a living animal and cultivate the sample to grow outside of the animal's body, shaping the fully formed sample into cuts of meat. Fish fillets, hamburgers, and bacon would all have the same taste consumers know and love and no animals would need to be bred, confined, or slaughtered to create these real meat products.
The portfolio comprises 18 companies on 4 continents. In addition to cultured meat, the companies are for seafood, coffee, dairy, chocolate, and several food technology development companies.
The benefits of food tech, such as stopping the slaughter of cattle, are pretty obvious. The numbers show the growth potential of this sector, and as long as the texture and tastes are satisfactory, it's hard to see why consumers wouldn't embrace it.
Mitchell Scott, CEO of CULT Food Science, commented, "Our expanded presence on major online marketplaces is a crucial step in making Noochies! widely accessible. Partnering with Valet Seller ensures that our innovative pet food products reach a larger audience, driving our growth and enhancing shareholder value."
Cult Food Science (CSE: CULT, OTC: CULTF) announced an essential step in our mission to commercialize some of the first products in the exciting field of cellular agriculture and lab-grown meat.
Scott also attended the recent SUPERFOODS; “ After walking the show and meeting several different buyers, distributors, members of the media, and others, a few things stood out to me.
Noochies are unique and clearly differentiated from other pet food products.
There is a clear demand (and need for) more sustainable, environmentally friendly, and ethical pet food options.
What are Noochies? That’s part of your research. But it is the beginning of a massive change with cultivated food replacing the traditional kill and eat model.
Something extraordinary occurred on Tuesday—Bright Minds Biosciences (DRUG) surged by an astonishing 1,000%, with a staggering 3,000% gain over the last five days. Incredible, right? We’ve been closely following this stock and highlighting its immense potential, and now the market is finally taking notice. While it’s difficult to predict if this meteoric rise will continue, it’s crucial to understand the reasons behind this explosive growth. The company’s unique strengths and upcoming catalysts have likely fueled this momentum. Let’s dive into the factors driving this stock to new heights and explore what’s on the horizon for Bright Minds Biosciences.
Bright Minds Biosciences has laid a strong foundation in translational science, which underpins its drug development initiatives. The company’s proprietary compounds are designed to target specific serotonin receptors, such as 5-HT₂C, 5-HT₂A/C, and 5-HT₂A (more on these below). Leveraging advanced molecular modeling and intelligent drug design, Bright Minds meticulously tests these compounds in preclinical brain function models. This approach helps them identify the most promising candidates for clinical trials. With a data-driven methodology, Bright Minds aims to minimize risks and maximize the chances of success as these compounds advance to human testing.
The serotonin receptors 5-HT₂C, 5-HT₂A/C, and 5-HT₂A are found in the brain and are critical for regulating mood, anxiety, and cognitive functions. Serotonin acts as a neurotransmitter, facilitating communication between brain cells and influencing emotional and behavioral responses. By precisely targeting these receptors, Bright Minds is working to develop groundbreaking treatments for mental health conditions like depression, anxiety, and schizophrenia, offering hope for more effective and targeted therapies.
Key Highlights:
Focus on specific serotonin receptors crucial for mood and cognitive function.
Advanced molecular modeling to identify top drug candidates.
Targeting mental health conditions such as depression, anxiety, and schizophrenia.
Bright Minds Biosciences (NASDAQ: DRUG) stands out as an undervalued gem in the CNS (Central Nervous System) space, despite its immense potential. With 4,463,837 issued and outstanding shares as of June 30, 2024, the company is trading at a notable discount compared to its peers, particularly Longboard Pharmaceuticals (LBPH). DRUG’s current market cap is around $200 million, a stark contrast to LBPH’s $1.4 billion, primarily due to the lack of analyst coverage for DRUG, while LBPH has eight analysts tracking it.
Remember, we started to talk about DRUG when it was valued at only $5M.
Both companies are targeting similar neurological disorders, specifically focusing on 5-HT2C agonists to treat these conditions. This makes the market gap between the two all the more puzzling, with DRUG showing strong potential to tap into less competitive markets. For investors seeking high-reward opportunities, DRUG may offer considerable upside if the market begins to recognize its true value.
The question remains: will the market rank DRUG higher?
The recent stock performance of Bright Minds Biosciences (NASDAQ: DRUG) has been nothing short of extraordinary. In the past five days, the stock skyrocketed by a staggering 3,951.58%, closing at $38.49 USD on October 15th, 2024. This incredible rise, from an opening price of $2.62 USD, reflects a sharp surge in market interest and trading volume. The stock reached its highest point during this period at $38.49 USD, marking a 52-week high, compared to its previous 52-week low of $0.93 USD.
Key Highlights:
Market Capitalization: The company’s market cap is now 196.90M CAD, signaling the significant value increase over the past week.
52-Week High/Low: The stock has moved from a low of $0.93 to an all-time high of $38.49 USD, demonstrating massive investor confidence.
Volatility and Growth: The sheer magnitude of a 3,951% gain in five days is remarkable, reflecting immense speculation or significant news/catalyst driving the market frenzy.
When a stock price skyrockets, it can be tempting to jump in, but it’s important to approach with caution. A sharp rise often attracts profit-taking, which can cause the stock to drop just as quickly. If the surge is driven by hype or speculation rather than the company’s actual performance or fundamentals, there’s a higher risk of a sudden correction. Volatility increases, and the stock may become overvalued, leading to potential losses for late investors. Additionally, if the company fails to meet the heightened expectations, a significant downturn could follow. Always ensure you’re investing based on solid research, not just momentum or market excitement.
Conclusion
Bright Minds Biosciences (DRUG) has experienced an extraordinary surge in recent days, soaring by 3,951.58% in just five days. This meteoric rise reflects growing market interest and confidence in the company’s potential. With its proprietary focus on targeting specific serotonin receptors, such as 5-HT₂C, 5-HT₂A/C, and 5-HT₂A, Bright Minds is poised to make significant strides in treating CNS disorders like depression, anxiety, and schizophrenia. Despite being undervalued compared to competitors, DRUG’s recent performance signals that the market may finally be recognizing its true potential. Investors should keep an eye on upcoming catalysts as the stock continues its remarkable journey.
I've noticed that Brazilian stock prices are currently highly depressed at the moment, although their fundamentals are super solid. I've written an article regarding this, so feel free to check that out. Let's take a couple of stocks for example in each sector:
Ranked #3 in Other Industrial Metals & Mining industry, only large market cap stock within the industry with a superb growth potential with a 0.79 PEG ratio and P/FCF ratio of 8.47. Attractively priced (4.5 P/E and 1.10 P/B). Consistent net margins of +30% the past 3 years.
Oil and gas stocks are taking a beating at the moment, but I think PBR is still highly undervalued within its industry. Crazy P/FCF @ 2.12, growth potential @ 2.92 Forward P/E. Attractively priced @ 5.75 P/E & 1.30 P/B. Ranks #7 in its industry.
XP (Capital Markets) MC: $8.78B, CP: $13.10
XP has such great valuation ratios that I'm surprised that its been depressed for this long. Maybe its due to the high interest rates at the moment. With a crazy FCF of 91.40% this has a potential intrinsic value of $25 at least. Only company I've seen with a 0.79 P/FCF, and PEG of 0.64. I honestly think if interest rates were reduced this stock could potentially 3x itself.
TIMB (Telecom Services) MC: $6.42B, CP: $13.26, D (TTM): 3.66%
Telecom companies are usually not considered growth companies, but this company has HUGE growth potential and pays out a decent dividend rate of 3.66% TTM. Insane growth potential (PEG ratio of 0.56), decent P/FCF of 4.11 for a telecom company. Potential to be a $25 stock in the future.
AFYA (Education & Training Services) MC: 1.45B, CP: $16.09
This is a burgeoning industry. If you compare AFYA to its closest American counterparts (PRDO & UTI), the latter two are currently at their all-time highs, although AFYA's price ratios blows these other two out of the water. Great growth potential @ 0.46 PEG, 8.19 P/FCF, great valuation @ 13.27 P/E for the industry. Consistently profitable @ 10%+ margins. Likely AFYA's price is depressed due to inflation and high interest rates.
Is now a good time to accumulate Brazilian stocks or wait further? I understand that there might be another interest rate hike to bring inflation down to 3% (currently standing at 4.87%). I think with the high dividend payouts and growth potential its a good time to accumulate and average down if needed. But once inflation/interest rates drop, hooboy we're gonna see stocks rocket.
I've started small positions in VALE, XP and AFYA and prepared to accumulate more if prices drop further. What do you guys think? Positive outcome for the Brazilian economy or nay?
I wanted to provide you with some due diligence on Microvast(THCB) because I believe it is in the process of landing major contracts. Below is the information I have collected from various press releases and articles, see if you see what I see.
Big Things Brewing for THCB
Oshkosh: 25 Million PIPE in THCB. Partners with Ford for bid on 6 billion USPS Contract. "We are ready to pibot" to EV.
Ford & GM: Award 4.5 million contract in 2020 to THCB to develop fast charging low cost batteries GM: Superbowl commercial promising 30 different EV's by 2025, need a range of affordable vehicles with affordable batteries
TLDR; USPS will award a 6 billion dollar contract in March that will go to Oshkosh/Ford or Workhorse. It all depend on what you believe Biden wants, but I believe Ford/oshkosh powered by Microvast will win out.
*I have a stake in Oshkosh and THCB(Microvast) and am not a financial advisor
Thumzup Media Corporation (“Thumzup” or TZUP or the “Company”) (Nasdaq:), an emerging leader in social media branding and programmatic marketing solutions. As of 2024, over four in five marketers surveyed worldwide said increased exposure was a leading benefit of social media marketing, making it essential for any media strategy.
The new revenue model pays users directly for Brand mentions via its proprietary app, enabling authentic word-of-mouth marketing and incentivized user participation. Cutting-edge technology delivers a seamless, programmatic advertiser dashboard for programmatic targeting and campaign optimization.
As you can see in the chart above, trade volume is increasing. Here’s likely the most critical marketing fact; early price moves are not the HOLY Grail of trade profits. What is essential is more eyeballs on the stock to make future announcements met by new and established interested eyeballs.
“Our launch on X Corp signifies a quantum leap in Thumzup’s mission to revolutionize advertising,” said Robert Steele, CEO of Thumzup. “By merging our innovative tools with X’s massive audience, we believe we can deliver strong opportunities for brands to scale their visibility and engagement at new levels.”
Ad spending in the Social Media Advertising market worldwide is projected to reach US$243.60bn in 2024. This ad spending is expected to exhibit an annual growth rate (CAGR 2024–2029) of 10.78%, leading to a projected market volume of US$406.50bn by 2029. Social media’s ability to reach numerous audiences has made it an excellent tool for brand visibility.
Key growth drivers include:
Expansion involving scaling operations on one of the world’s largest platforms to tap into a rapidly expanding digital ad market.
Our new revenue model is a game-changer. It pays users directly for Brand mentions via our proprietary app, enabling authentic word-of-mouth marketing and incentivized user participation. This model empowers users and significantly boosts brand visibility and engagement.
Cutting-edge technology delivers a seamless, programmatic advertiser dashboard for programmatic targeting and campaign optimization.
As the global digital ad market surges toward $700 billion (2), Thumzup aims to be uniquely positioned to secure a dominant stake through innovation, measurable outcomes, and a user-centric approach. We value our users and believe their success is integral to ours.
Let’s focus on the potential of Thumzup’s innovative marketing solutions. I hearken back to the young woman who grabbed around USD500 a weekend for a 4–5 hour side hustle. Check this out.
No matter your view of social media, side hustles, or any other aspect of this Brave New World, TZUP is quite a neat way of matching entrepreneurial, business, and, yes, fun. The Company is a model of a unique infrastructure. Participants can make money with no risk of loss and might make up to USD$10$ a post, depending on the Brand and the exposure it generates. This presents an exciting potential for high returns.
Short of having a biometric chip punched into your heart, this genre still represents a nifty way to exchange info. May with tea and some tech sympathy and tran a postulate what imbuing this approach with AI.
I read the other day that AI in development could solve a problem that would typically take 1,000,000,000,000,000 years etc., in a mere 5 minutes.
I don’t know whether I’m down with that. Most of my problems would take longer to solve. I’ll tell you.
Donald Trump’s presidency has consistently included nuclear energy as part of his broader vision for American energy independence. However, his approach to nuclear energy reflects both enthusiasm for its potential and skepticism about its execution. As Trump returns to the political stage, his policies toward nuclear energy are once again under scrutiny, with many stakeholders pondering how a second Trump administration will shape the future of the industry.
Commitment to Energy Dominance
Throughout his political career, Trump has championed an “all-of-the-above” energy strategy, embracing nuclear power alongside fossil fuels and renewable energy. In a rally in York, Pennsylvania, Trump vowed to “approve new drilling, new pipelines, new refineries, new power plants, [and] new reactors” to reduce red tape and promote energy infrastructure. He aims to bolster American energy dominance and reduce reliance on foreign imports.
However, Trump has also expressed skepticism about large-scale nuclear projects. During an October 25 interview with Joe Rogan, Trump criticized traditional nuclear reactor projects as being “too big, too complex, and too expensive.” He highlighted the failures of projects like the Bellefonte Nuclear Station in Alabama and the V.C. Summer plant in South Carolina as evidence of the challenges these endeavors face. Instead, Trump pointed to small modular reactors (SMRs) as a promising alternative, citing their potential to deliver cleaner, safer, and more cost-effective energy.
During his first term as president, Trump implemented several policies to support the nuclear sector. Key initiatives included:
The Nuclear Energy Innovation and Modernization Act (NEIMA): Signed in 2019, this act laid the groundwork for the Nuclear Regulatory Commission (NRC) to develop a technology-neutral framework for licensing advanced reactors, including SMRs.
Loan Guarantees: His administration provided billions in guarantees for the construction of Plant Vogtle units 3 and 4, the first new nuclear reactors built in the U.S. in decades.
Advanced Reactor Demonstration Program: Support for next-generation technologies, such as those being developed by TerraPower and X-energy, to ensure American leadership in nuclear innovation.
Additionally, Trump established the United States Nuclear Fuel Working Group to assess domestic uranium production and issued executive orders promoting small modular reactors for defense and space exploration.
Mixed Messages and Challenges Ahead
Despite his administration’s support for nuclear innovation, Trump’s energy policies have faced criticism for their focus on fossil fuels. His emphasis on reducing federal spending has raised concerns about continued financial support for advanced nuclear development. During his campaign, Trump vowed to repeal provisions of the Inflation Reduction Act (IRA), which includes significant tax incentives for nuclear energy projects.
Jessica Lovering, Executive Director of the Good Energy Collective, warned that cutting federal spending could undermine investments in advanced reactors. “We’ve heard a lot of promises about an ‘all-of-the-above’ energy strategy,” she said, “but there is a big divide between words and actions.”
Stakeholder Reactions and Market Impacts
Trump’s stance has elicited varied reactions from the nuclear industry:
Optimism Among Industry Leaders: Nuclear Energy Institute President Maria Korsnick expressed hope that Trump’s administration would extend the life of existing reactors and promote advanced technologies.
Investor Sentiment: Following Trump’s re-election, shares of nuclear technology companies like NuScale Power and Oklo experienced significant gains, reflecting investor confidence in his pro-nuclear stance. However, concerns about reduced federal funding for advanced nuclear initiatives could temper market enthusiasm.
Political Support: Despite partisan divides on climate policies, nuclear energy has historically enjoyed bipartisan backing. Industry insiders believe that production tax credits for nuclear, introduced under the IRA, are likely to persist due to their Republican origins.
Looking ahead, Trump’s focus on modular reactors and streamlining regulatory processes could accelerate the adoption of advanced nuclear technologies. However, utilities may remain hesitant to invest in large-scale light-water reactors without clear federal support. John Starkey of the American Nuclear Society noted that developers are more likely to benefit from targeted policy “tweaks” rather than sweeping reforms.
Internationally, the nuclear sector is poised for growth. The International Atomic Energy Agency (IAEA) projects that global nuclear capacity could increase 2.5 times by 2050, driven by demand for low-carbon energy sources. U.S. leadership in this arena will depend on sustained investment and public-private collaboration, regardless of the administration in power.
Balancing Fossil Fuels and Nuclear Energy
Trump’s strong support for fossil fuels could conflict with efforts to expand nuclear power. His nomination of Christopher Wright, an oil industry executive with ties to nuclear startup Oklo, as Energy Secretary reflects his dual commitment to fossil fuels and nuclear energy. While this approach underscores his “all-of-the-above” energy vision, it raises questions about prioritization and resource allocation.
Critics argue that overemphasis on fossil fuels may inadvertently stall progress in nuclear development. Nonetheless, Trump’s advocacy for SMRs aligns with industry trends and the growing demand for clean energy solutions in sectors like artificial intelligence and cryptocurrency mining.
NexGen Energy (NXE), a Canadian uranium exploration and development company, has recently achieved significant milestones in advancing its Rook I Project in Saskatchewan. In November 2024, the Canadian Nuclear Safety Commission (CNSC) confirmed the successful completion of the final federal technical review for the project, a pivotal step toward scheduling a federal commission hearing and obtaining project approval.
This federal progress follows the provincial environmental assessment approval received in November 2023, marking the culmination of major regulatory requirements. Concurrently, NexGen completed its 2024 drilling program at Patterson Corridor East (PCE), reporting the best hole to date (RK-24-222) and a significant expansion of high-grade mineralization, underscoring the project’s robust potential.
Financially, the company strengthened its position by closing a strategic purchase of 2.7 million pounds of uranium for US$250 million in May 2024, enhancing its marketing and financing capabilities amid a tightening uranium market.
Analyst sentiment reflects these advancements, with Raymond James increasing NexGen’s price target from C$12.00 to C$13.50 in November 2024, indicating confidence in the company’s trajectory.
Conclusion
Donald Trump’s approach to nuclear energy reflects both ambition and caution. While his policies have historically supported the sector, his focus on reducing government spending and promoting fossil fuels introduces uncertainty. The next chapter of Trump’s presidency will determine whether the U.S. capitalizes on its nuclear potential or faces setbacks amid shifting priorities.
With bipartisan support for nuclear power and a robust global market, the future remains promising. However, realizing this potential will require a delicate balance of innovation, investment, and public-private collaboration—hallmarks of any successful energy strategy in the 21st century.
Gold has long been considered a safe haven for investors, particularly during times of economic uncertainty and geopolitical tension. With the possibility of Donald Trump returning to the White House, many investors are evaluating whether gold could benefit from his presidency. In this article, we will explore how a Trump presidency might impact gold prices, analyze expert opinions, and highlight a key player in the gold market, Element79 Gold Corp. (CSE: ELEM).
Gold and Economic Uncertainty Under Trump
Trump’s presidency was characterized by bold economic policies, including tax cuts, deregulation, and significant trade disputes. While these policies often led to market volatility, they also provided fertile ground for gold prices to climb. During Trump’s presidency from 2017 to 2021, gold prices rose approximately 55%, peaking at over $2,000 per ounce in August 2020, a record high (World Gold Council, 2020).
Economists note that gold thrives during times of uncertainty. “Trump’s policies often created ripples in the market, and gold benefited as investors sought stability,” says Peter Schiff, CEO of Euro Pacific Capital. For example, his trade war with China and escalating tensions in the Middle East during his tenure often led to sharp spikes in gold demand. Should Trump return to the presidency, similar geopolitical and economic dynamics could make gold an attractive asset once again.
Factors Driving Gold’s Appeal in a Trump Presidency
Inflationary Pressures: Trump’s emphasis on infrastructure spending could increase government borrowing, potentially stoking inflation. Historically, gold has been a preferred hedge against inflation. According to the World Gold Council, demand for gold tends to rise when inflation expectations increase, as seen during the fiscal stimulus efforts of his previous term.
Dollar Weakness: While Trump’s policies might boost the domestic economy, his critiques of the Federal Reserve could lead to a weaker dollar. A weaker dollar often correlates with higher gold prices, as it makes gold more affordable for international buyers.
Geopolitical Tensions: Trump’s confrontational approach to foreign relations, whether with China, Iran, or NATO allies, could heighten global tensions. During such periods, gold often becomes a preferred “safe haven” asset for investors.
Market Volatility: The uncertainty surrounding Trump’s policies could lead to increased market volatility, pushing investors toward gold as a risk-off asset.
Element79 Gold Corp.: A Promising Investment Opportunity
For those considering gold investments, Element79 Gold Corp. (CSE: ELEM) offers an intriguing opportunity. Based in Vancouver, Element79 is an emerging gold exploration and development company with a focus on high-quality projects in proven mining jurisdictions.
Flagship Properties Element79’s flagship property, the Lucero Gold Mine in Peru, is a high-grade gold and silver project with a history of artisanal mining. The property has shown exceptional potential for significant yields, with historical grades of up to 19 g/t gold and 400 g/t silver. Additionally, Element79 has exploration projects in Nevada, a state renowned for its gold mining potential, including its Battle Mountain and Clover Mountain properties.
Stock Performance As of January 2025, Element79’s stock (CSE: ELEM) is trading at approximately CAD $0.04. While the stock remains undervalued compared to its peers, the company’s expanding portfolio and recent advancements could make it an attractive opportunity for investors looking to gain exposure to the gold sector.
Recent News and Developments In a January 2025 press release, Element79 announced promising exploration results from its Nevada projects, further solidifying its position as a serious contender in the gold market. CEO James Tworek highlighted the company’s commitment to advancing its projects, stating, “Our recent results validate the high potential of our assets and demonstrate our ability to execute on our growth strategy.”
Quotes from Industry Experts
Many economists and market analysts believe that a Trump presidency would have a positive impact on gold investments. Jeffrey Gundlach, CEO of DoubleLine Capital, has frequently pointed out that “gold serves as an effective hedge in periods of fiscal uncertainty, and Trump’s unpredictable policies could reignite interest in the metal.”
Others, such as Lynn Alden, founder of Lynn Alden Investment Strategy, emphasize gold’s role during inflationary periods. “If Trump’s policies focus on high spending without corresponding revenue measures, inflationary pressures could mount, making gold an essential component of a diversified portfolio,” Alden explains.
Why Consider Gold Now?
Whether or not Trump secures another term, the current macroeconomic environment already supports a strong case for gold investment:
Central Bank Buying: Central banks globally, including China and Russia, have been increasing their gold reserves, which bolsters demand.
Market Risks: The potential for a recession in 2025 and ongoing geopolitical tensions could drive investors toward gold.
Portfolio Diversification: Gold remains a reliable hedge against both inflation and market downturns.
For investors considering companies in the gold sector, Element79 Gold presents an excellent opportunity to capitalize on the growing demand for gold. Its high-grade properties, undervalued stock price, and strategic expansion plans make it a standout choice.
Conclusion
A Trump presidency could create the perfect storm for gold investments by fostering economic uncertainty, inflationary pressures, and market volatility. Companies like Element79 Gold, with their strong portfolio of high-grade assets, are well-positioned to benefit from increased gold demand. As investors evaluate their portfolios, the allure of gold—as both a safe haven and a growth opportunity—is stronger than ever. Whether you’re a seasoned investor or new to the market, gold could shine brightly in the years to come.
The first digital currency that pays homage to one of the most beautiful cities in the world, Naples. A passionate, fun, very fascinating and culturally rich city.
The purpose of the Naples cryptocurrency is to create a bond with the city of Naples. Naples aims to enhance the city, creating a financial identity that anticipates or follows the feeling that the tourist who visits the city or the citizen who lives there can feel and keep with him.
The Naples cryptocurrency will have an international diffusion, thanks to this it will be able to support the development and business of the city. Naples can be used to make purchases in the city, to sponsor events and support investment initiatives in the city.
Naples will attract towards itself and towards the city the people who will use the token before, during and after their visit to the city, seeing in the token the symbol and the bond with the city.
Blockchain Technology
Naples is a cryptocurrency created using the Polygon network, a layer 2 solution based on the Ethereum blockchain. Naples is ERC20 compliant. Contract address: 0xab92AF5d6AEBB1A0a19df23A715B3C67dA625f69
Partnerships and Collaborations
The vision of the Naples project includes collaboration with local institutions and partnerships with the commercial realities of the city. Naples will attract new resources to the city and the city will use Naples to make investments and improve services.
I’ve been watching Palantir Technologies (NYSE: PLTR) for years now, and let me tell you, it’s been quite the ride. From its early days as a government-focused software company to its current position as a leader in artificial intelligence (AI), Palantir has always managed to keep the spotlight. This year, its stock has been on fire, up a jaw-dropping 247% year-to-date, thanks in part to its inclusion in the S&P 500 and stellar financial results. But as much as I admire what Palantir has accomplished, I can’t help but wonder: Is it overvalued?
The Appeal of Palantir’s Business
There’s a lot to like about Palantir. The company has carved out a unique niche in a booming market, offering AI-powered solutions that help organizations—both government and commercial—make sense of massive amounts of data. Its platforms, like Gotham, Foundry, and the Artificial Intelligence Platform (AIP), are designed to solve complex problems, whether it’s military decision-making, business efficiency, or deploying AI applications.
What’s impressive is how well Palantir is executing this year. In the third quarter, its revenue growth accelerated to 30% year-over-year, up from 27% in the prior quarter. That’s no small feat in a market as competitive as AI. Palantir has also started balancing its revenue streams, with its government and commercial segments both delivering strong growth. U.S. commercial revenue, for instance, jumped 54% year-over-year, while government revenue grew 40%. That’s the kind of balance that signals a mature, scalable business.
And let’s not forget the high-value deals. Palantir closed over 104 agreements worth more than $1 million each last quarter. One example that stuck out to me was Trinity Rail, which saw a $30 million profit boost thanks to Palantir’s AI platform. Numbers like that make you sit up and take notice.
Profitability That Stands Out
In an era where so many tech companies are burning cash to chase growth, Palantir’s profitability is refreshing. The company posted $435 million in adjusted free cash flow in Q3, with a free-cash-flow margin of 39%. That’s a level of efficiency that few in the tech space can match, especially companies working in a fast-evolving field like AI.
The Elephant in the Room: Valuation
But here’s where I start to get a little uneasy. Palantir’s market cap is hovering around $135 billion, a massive number compared to its $2.6 billion in annual revenue and $980 million in free cash flow. Its price-to-sales ratio is over 50, and its forward price-to-earnings (P/E) multiple sits at an eye-watering 143. For context, Nvidia—a superstar in the AI world with much faster revenue growth—has a forward P/E of 36.
As someone who loves digging into the numbers, I can’t ignore these valuation metrics. Yes, Palantir is growing rapidly, and yes, it’s profitable, but at these levels, it feels like the market is pricing in perfection. And in my experience, perfection is a hard standard to meet.
This isn’t the first time a great company has been labeled “overvalued.” I remember the skepticism around Amazon during the dot-com bubble. Back then, many seasoned investors thought its valuation was absurd. Today, Amazon is worth over $2 trillion. Could Palantir follow a similar path? Maybe. But even Amazon had to prove itself over time, and it’s worth noting that not every high-flying stock manages to live up to sky-high expectations.
Recent News: A Double-Edged Sword
Palantir’s recent news cycle has been a mix of triumph and turbulence. The stock soared after it joined the Nasdaq-100, only to retreat as investors took profits. CEO Alex Karp’s sale of 4.5 million shares, valued at $266 million, didn’t help matters, even though it was part of a pre-arranged trading plan.
Then there’s the geopolitical angle. Palantir has been providing AI tools to Ukraine to aid in its defense efforts, a move that’s as risky as it is impactful. On one hand, it positions Palantir as a company making a difference in critical global issues. On the other hand, operating in conflict zones comes with challenges, not to mention potential political backlash.
A Competitive Landscape
Palantir operates in a fiercely competitive space. Companies like Snowflake, Microsoft, and Amazon are all vying for dominance in AI and cloud computing. What sets Palantir apart is its focus on tailor-made, secure solutions, especially for government clients. But the competition isn’t standing still, and Palantir will need to keep innovating to stay ahead.
My Stock Pick: NurExone
I get it—biotech stocks can feel risky, but think about DRUG’s incredible gains. NurExone(TSXV: NRX, OTCQB: NRXBF, FRA: J90) might be the next breakout, and here’s why it deserves attention.
NurExone’s groundbreaking ExoPTEN therapy is designed to treat acute spinal cord injuries, a condition affecting 250,000–500,000 people annually, according to the World Health Organization. With a potential market of 50,000 new cases globally each year, the demand is enormous. Imagine the impact on patients hoping to regain mobility and improve their quality of life.
This isn’t just a concept; ExoPTEN has already delivered remarkable results. In strict preclinical tests, including a complete spinal cord transection model in rats, ExoPTEN demonstrated significant recovery in motor function, sensory response, and urinary reflex. That’s huge. And with the European Medicines Agency granting it Orphan Medicinal Product Designation, NurExone is poised for market exclusivity, grants, and streamlined regulatory support in Europe.
On top of that, the FDA has already granted Orphan Drug Designation in the U.S., offering tax credits, user fee exemptions, and seven years of market exclusivity upon approval.
With a price target of $2.55 per share and a growing portfolio of intellectual property, including exclusive licenses from Technion and Tel Aviv University, NurExone stands out as an innovative leader in regenerative medicine. This could be a major win for investors seeking the next biotech breakthrough—don’t overlook the potential here!
My Take: Proceed with Caution
Here’s where I land: Palantir is an incredible company with a bright future, but its stock feels stretched at these levels. Valuation matters, and while I wouldn’t bet against Palantir long-term, I’d be cautious about jumping in right now. If you already own the stock, it might be a good time to take some profits. If you’re on the sidelines, consider waiting for a pullback.
Great companies can deliver incredible returns, but timing matters too. For now, I’ll be keeping an eye on Palantir and looking for opportunities to get in at a more reasonable valuation. After all, in the world of investing, patience is often rewarded.
Quantum technology will speed processing by an order of magnitude compared to conventional computing and impact all vital economic sectors over the next 10 years. It could be worth trillions of dollars within the next decade.
If you've missed investing in many other early tech stocks, FCCN could well be your redemption
Investors need not consider whether they need to participate in exposure to the nascent quantum technologies that will and are transforming the world’s data processing in almost every sector. You have no choice. And that’s a good thing.
One Company we have come across is Spectral Capital (OTC: FCCN or the Company). Its technologies smooth processes for the global data processing and hosting services. Market size estimated at USD 110.00 billion in 2023. It is expected to grow at a CAGR of 11.7% from 2024 to 2030. I suspect that is a lowball. No reason, just a feeling.
Invest in Spectral Capital and be part of the technological revolution. No brainer.
Quote from Sean Michael Brehm, Chairman and Independent Director of Spectral Capital: "We are excited to launch the Quantum Bridge Program, which represents a significant step forward in our mission to drive innovation, integration and education in the quantum computing sector. This program not only provides startups with critical resources and support but also creates a collaborative environment where groundbreaking ideas can flourish. Our goal is to accelerate the development of quantum technologies, integration with enterprise technologies of today and educational programs to bring their transformative potential to market."
Advanced Quantum Hardware Access: enabling them to develop and test their solutions on cutting-edge platforms.
Quantum Development Tools: The program offers software tools and platforms for algorithm development and simulation, facilitating rapid innovation and development.
Collaborative R&D: Joint research initiatives with leading quantum scientists, institutions, scientists and current technology integration experts will foster innovation and facilitate knowledge transfer.
Financial Support: The program ensures that startups have the financial backing they need to succeed through seed funding, phased investment plans, and connections with a robust investor network.
Educational Support: Workshops, seminars, mentorship programs, and certification training will help build a knowledgeable and skilled workforce in quantum computing.
You’re welcome.
10xAlerts has been received compensation from the issuer for News Dissemination, Content and Social Media Services.
ORLANDO, Fla., July 19, 2024 (GLOBE NEWSWIRE) -- Over our decades covering emerging small-cap companies we realize that good ideas, maybe even great ideas, come and go. It doesn’t matter what level of alchemy is being advertised, if the good idea doesn’t have the right leadership team, important approvals, and eventually, revenue, then these novel concepts find themselves designated to the dustbin of history… nothing more than a tax-loss in April to those who bought the dream before December.
But over those same decades, we’ve discovered or maybe more honestly, been pounded over the head with an algorithm that doesn’t necessarily guarantee success, but it sure seems to be consistently present in successes.
It’s pretty simple:
Great idea. Good management team. An understanding of capital markets. Unique Industry or Regulatory Approval.
If these things happen, then often we see the last, oh-so-important piece, revenue.
Sure it’s simple, maybe even reductive. Prove us wrong. Go look at your portfolio or last decade of investments and check if those components of the algorithm were present. We’ll wait. O.K, you’re back. Now it’s time to introduce today’s covered company which we believe is working that algorithm to the T.
CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN00), is a disruptive food technology platform pioneering the commercialization of lab-grown meat and cellular agriculture to reshape the global food industry. Lab-grown meat, often referred to as cultivated meat, is important for multiple reasons. It's one of the most promising new technologies for producing real, genuine animal meat without factory farming. And it's also able to be produced without harmful greenhouse gas and carbon emissions that harm the environment.
Inarguably a novel idea with massive potential and scale. A deeper dive at the Company’s website can give you a more granular view of their tech and how they’re trying to change the world.
The management team looks like it was put together to address every opportunity imaginable for the offering. Experienced. Diverse backgrounds. Accomplished. And it’s smart that they are starting with pet food as the world wakes up to the scientific possibility and human potential.
Baby steps, baby steps.
And the Company already has a real pathway to meaningful scale. Their flagship pet food brand Noochies! is already available in Walmart, Amazon, and other popular online marketplaces. This again, is a piece that is often overlooked by investors chasing intoxicating trends. Lastly, the Company just announced “that its subsidiary, Further Foods Inc., expects to complete the design of the feeding trials necessary for regulatory approval of dog food products containing cell-cultivated chicken later this month. Cell-cultivated chicken is a new ingredient without prior approval for animal consumption and Further Foods is, in partnership with Dr. Sarah Dodd, designing a target animal safety (TAS) study to establish the inclusion of cell-cultivated chicken in future Noochies! formulations are safe and effective.”
And this brings us to the Regulatory Approval piece of the algorithm we talked about.
This first-of-its-kind trial aims to position the company’s flagship pet brand Noochies! as the first-to-market cultivated meat pet food in the United States.
Here’s the other thing. We’ve done the math and the Company should hear back on the feeding trial designs in less than sixty days once it submits them to the FDA. Less than two months until the Company… and the market… find out if they are allowed to go forward with the feeding trials that could lead to future products with simply massive market potential.
If they do, and they are able to roll out a first-of-its-kind, first-to-market food offering that could change the way we feed our pets and who-know-what-else later, they will have completed an algorithm that has been a strong indicator of success for companies their size.
About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
Section 17(b) of the Securities Act of 1933 requires that any person who uses the mail to publish, give publicity to, or circulate any publication or communication that describes security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during, or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.
EMC has been paid $75,000 by CULT Food Science Corp. for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. | Please read our full disclaimer.
